Rauck, MD, Richard L., United States

• Journal of Opioid Management Vol. 2 No. 3 (2006): May/June - Articles
  The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain
  Abstract  PDF
• Journal of Opioid Management Vol. 2 No. 6 (2006): November/December - Articles
  A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial
  Abstract  PDF
• Journal of Opioid Management Vol. 3 No. 1 (2007): January/February - Articles
  A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial
  Abstract  PDF
• Journal of Opioid Management Vol. 15 No. 5 (2019): September/October - Articles
  Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone
  Abstract
• Journal of Opioid Management Vol. 17 No. 7 (2021): Special Issue - "Buprenorphine: Clinical and Public Policy Implications" - Articles
  Atypical opioids and their effect on respiratory drive
  Abstract
• Journal of Opioid Management Vol. 5 No. 2 (2009): March/April - Articles
  Long-term safety, tolerability, and efficacy of OROS® hydromorphone in patients with chronic pain
  Abstract